Your session is about to expire
← Back to Search
Progesterone + Estradiol for Polycystic Ovary Syndrome
Study Summary
This trial will study the effect of 7 days of estrogen and progesterone on GnRH pulses in girls and women with PCOS, in order to understand why some women have higher levels of male hormone and develop PCOS.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many people have consented to participate in this research?
"At this juncture, the trial is not recruiting patients. The study was first listed on April 1st 2000 and edited for the last time on June 23rd 2022. There are currently 96 trials searching for participants with sclerocystic ovaries and 82 studies looking to recruit volunteers taking Progesterone medication."
In what medical scenarios is Progesterone typically recommended?
"Progesterone is a viable treatment option for women with hypoestrogenism and vasomotor symptoms associated with menopause who have not had their menstrual period in the past 6 months."
Could you elaborate on the prior research done with Progesterone?
"Presently, 82 clinical trials pertaining to progesterone are underway. Fifteen of these studies have entered Phase 3 and 851 separate medical sites are participating in the research. Cheras, Kuala Lumpur appears to be a primary hub for Progesterone-related investigations."
Is this research project open to participants who are over the age of 30?
"As per the study's criteria, only those aged 8-18 are eligible for enrolment."
What criteria makes someone an ideal candidate for this research project?
"This research is searching for 60 pre-adolescents and adolescents with sclerocystic ovaries. The ideal candidate should be between 8 to 18 years old, hyperandrogenemic (elevated testosterone levels or hirsutism), and have standard laboratory values (excluding the hormonal abnormalities associated with hyperandrogenemia)."
Are there any vacancies within this trial for prospective volunteers?
"This clinical trial is no longer seeking applicants. It was first announced on April 1st 2000 and its registration details were last updated on June 23rd 2022. For those searching for other medical trials, 96 are actively recruiting patients with sclerocystic ovaries and 82 are currently looking for participants that can receive Progesterone treatment."
Share this study with friends
Copy Link
Messenger